BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Perisetti A, Goyal H, Yendala R, Thandassery RB, Giorgakis E. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. World J Gastroenterol 2021; 27(24): 3466-3482 [PMID: 34239263 DOI: 10.3748/wjg.v27.i24.3466]
URL: https://www.wjgnet.com/1948-5182/full/v27/i24/3466.htm
Number Citing Articles
1
Mohamed Kohla, Reham Ashour, Hossam Taha, Osama El-Abd, Maher Osman, Mai Abozeid, Sally Waheed ELKhadry. Prognostic performance of Hong Kong Liver Cancer with Barcelona Clinic Liver Cancer staging systems in hepatocellular carcinomaBMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03387-5
2
Chunyan Yuan, Jing Peng, Renxiang Xia, Jian He, Tianji Qiu, Yunqing Yao. Reactivation of Occult Hepatitis B Virus Infection During Long-Term Entecavir Antiviral TherapyFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.865124
3
Luckshi Rajendran, Woo Jin Choi, Hala Muaddi, Tommy Ivanics, Jordan J. Feld, Marco P. A. W. Claasen, Matthew Castelo, Gonzalo Sapisochin. Association of Viral Hepatitis Status and Post-hepatectomy Outcomes in the Era of Direct-Acting AntiviralsAnnals of Surgical Oncology 2023; 30(5): 2793 doi: 10.1245/s10434-022-12937-8
4
Kuo Du, Ji Hye Jun, Rajesh K. Dutta, Anna Mae Diehl. Plasticity, heterogeneity, and multifunctionality of hepatic stellate cells in liver pathophysiologyHepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000411
5
Saleh A. Alqahtani, Wah-Kheong Chan, Ming-Lung Yu. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular CarcinomaClinics in Liver Disease 2023; 27(2): 211 doi: 10.1016/j.cld.2023.01.019
6
X Zhu, Q Feng, X Ge, B Hu. Using conventional contrast-enhanced MRI semi-quantitative analysis to distinguish alpha-fetoprotein-negative small hepatocellular carcinoma without cirrhosis and small focal nodular hyperplasiaInternational Journal of Radiation Research 2024; 22(3): 625 doi: 10.61186/ijrr.22.3.625
7
Qinglin Zhang, Jiadong Pan, Fangmei An, He Nie, Qiang Zhan. Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinomaBioengineered 2021; 12(1): 8147 doi: 10.1080/21655979.2021.1987131
8
Irfan A. Kazi, Vinay Jahagirdar, Bareen W. Kabir, Almaan K. Syed, Asad W. Kabir, Abhilash Perisetti. Role of Imaging in Screening for Hepatocellular CarcinomaCancers 2024; 16(19): 3400 doi: 10.3390/cancers16193400
9
Carly Lamb, Jennifer Tham, Tee Lin Goh, Stephen Barclay, Matthew Priest, Ewan H Forrest, Andrew Fraser, David Kay, Ram Kasthuri, Jeff Evans, Adrian J Stanley. Comparison between patient characteristics, aetiology and outcomes in patients with and without cirrhosis with hepatocellular carcinoma diagnosed in a regional centreFrontline Gastroenterology 2024; 15(5): 380 doi: 10.1136/flgastro-2024-102676
10
Ellery Altshuler, Raymond Richhart, Mahmoud Aryan, William King, Kelsey Pan, Akash Mathavan, Akshay Mathavan, Diana Rodriguez, Bishal Paudel, Nathan Northern, Brian Ramnaraign, Ilyas Sahin, Jesus C Fabregas. Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective ReviewJournal of Hepatocellular Carcinoma 2022; : 1299 doi: 10.2147/JHC.S384438
11
Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Silvia Gaia, Emanuela Rolle, Alessandra Risso, Daniela Campion, Paola Rita Brunocilla, Giorgio Maria Saracco, Patrizia Carucci. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West ItalyCurrent Oncology 2022; 29(3): 1422 doi: 10.3390/curroncol29030119
12
Heng-Tong Han, Wei-Lin Jin, Xun Li. Mesenchymal stem cells-based therapy in liver diseasesMolecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00088-x
13
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, Parastoo Fooladpanjeh, Neda Faal Hamedanchi, Nima Broomand Lomer, Arian Karimi Rouzbahani, Mohammad Reza Naimi-Jamal. Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and ImmunotherapyLivers 2023; 3(1): 121 doi: 10.3390/livers3010011
14
Mahmoud Aryan, Thomas Ruli, Mohamed Shoreibah. HCC in patients without cirrhosis: A reviewClinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000224
15
Jiaojiao Gong, Renjie Yu, Xiaoxia Hu, Huating Luo, Qingzhu Gao, Yadi Li, Guili Tan, Haiying Luo, Bo Qin. Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2023; : 1609 doi: 10.2147/JHC.S424545
16
Reshmi Mathew, Gregory Churchill, Bakht Cheema, Ketav Desai, Ahmad Alkhasawneh, Shiguang Liu, Anwer Siddiqi. Concomitant Gastric Malignancy and Hepatocellular CarcinomaCureus 2022;  doi: 10.7759/cureus.25607
17
Yu Jiang, Shulin Chen, Yaxian Wu, Yuanye Qu, Lina Jia, Qingxia Xu, Shuqin Dai, Ning Xue. Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinomaCancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02725-5
18
Yan Zhu, Zhishuai Li, Jixiang Zhang, Mingqi Liu, Xiaoqing Jiang, Bin Li. Identification of crucial lncRNAs and mRNAs in liver regeneration after portal vein ligation through weighted gene correlation network analysisBMC Genomics 2022; 23(1) doi: 10.1186/s12864-022-08891-0
19
H. Peris Alvà, C. Cano Rodríguez, F. Bosch Barragan, A. Framis Utset, F. Novell Teixidó, M.J. Prieto del Rey. Lesiones hepáticas de nueva aparición en el paciente oncológico: un reto diagnósticoRadiología 2023;  doi: 10.1016/j.rx.2023.07.004